Targeted Therapies and Collaborative Care in AD and PN

The NACE Clinical Highlights Show

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/collaborative-care-in-atopic-dermatitis-and-prurigo-nodularis-9892
Summary
In this concise CME/CE podcast, a dermatologist and primary care clinician review treatment options for patients with atopic dermatitis and prurigo nodularis. Using case examples, the clinicians provide education on individualizing treatment by evaluating patients for treatment progress, modifying treatment plans, and using shared decision-making.
Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Develop a treatment plan for managing patients with AD and/or PN based on current guidelines and evolving clinical data, including specialty referral when appropriate
• Apply communication strategies to facilitate SDM in the management of patients with AD and PN to improve adherence and outcomes

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at [e-mail].
Summary of Individual Disclosures
Please review faculty and planner disclosures here.
Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals, Inc.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.